Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL)
Clinical trial NCT00141323 · COMPLETED
Trial details
- NCT number
- NCT00141323
- Sponsor
- Ligand Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-11-01
- Primary completion
- 2007-12-01
- Enrollment
- 8556
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.